Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02254980 |
Date of registration:
|
30/09/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Migration and Head Penetration of Vitamin-E Diffused Cemented Polyethylene Cup in Total Hip Arthroplasty
E1-hip |
Scientific title:
|
Migration and Head Penetration of Vitamin-E Diffused Cemented Polyethylene Cup Compared to Standard Cemented Cup in Total Hip Arthroplasty. A Randomized, Single-blinded, Clinical Trial |
Date of first enrolment:
|
February 2013 |
Target sample size:
|
44 |
Recruitment status: |
Active, not recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02254980 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Sweden
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Primary osteoarthritis of the hip
- Willingness and ability to follow study-protocol
Exclusion Criteria:
- Inflammatory arthritis or secondary osteoarthritis.
- Type C (stove pipe) femur
- Abnormal femoral or pelvic anatomy after hip dysplasia, not suitable for implantation
of components
- Treatment with bisphosphonates, cortisol or cytostatic drugs 6 months prior to surgery
- Ongoing oestrogen treatment
- Not suited for the study for other reason (surgeons preference)
Age minimum:
40 Years
Age maximum:
75 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Total Hip Arthroplasty
|
Intervention(s)
|
Device: Standard polyethylene acetabular component
|
Device: Vitamin-E diffused polyethylene acetabular component
|
Primary Outcome(s)
|
Cup migration
[Time Frame: 2 years]
|
Secondary Outcome(s)
|
Complication rate
[Time Frame: 10 years]
|
Cup migration total
[Time Frame: 2 years]
|
Functional outcome
[Time Frame: 2 years]
|
Linear wear
[Time Frame: 2 years]
|
Osteolysis
[Time Frame: 2 years]
|
Linear wear
[Time Frame: 4 years]
|
Osteolysis
[Time Frame: 10 years]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|